全部照片(2)
About This Item
經驗公式（希爾表示法）:
C16H18N2Na2O14S2
CAS號碼:
分子量：:
572.43
MDL號碼:
分類程式碼代碼:
12352106
PubChem物質ID:
NACRES:
NA.22
推薦產品
品質等級
化驗
≥95% (H-NMR)
形狀
powder
反應適用性
reagent type: cross-linking reagent
溶解度
H2O: 10 mg/mL
DMF: soluble
儲存溫度
−20°C
SMILES 字串
[Na+].[Na+].[O-]S(=O)(=O)C1CC(=O)N(OC(=O)CCCCCCC(=O)ON2C(=O)CC(C2=O)S([O-])(=O)=O)C1=O
InChI
1S/C16H20N2O14S2.2Na/c19-11-7-9(33(25,26)27)15(23)17(11)31-13(21)5-3-1-2-4-6-14(22)32-18-12(20)8-10(16(18)24)34(28,29)30;;/h9-10H,1-8H2,(H,25,26,27)(H,28,29,30);;/q;2*+1/p-2
InChI 密鑰
MGJYOHMBGJPESL-UHFFFAOYSA-L
一般說明
双(3-磺基-N-羟基琥珀酰亚胺酯)辛二酸酯钠盐（BS3）是水溶性同源双功能交联剂，具有胺基反应活性。它通常在pH 7.5（6.5-8.5）的缓冲条件下通过酰胺键与含有伯胺的分子偶联。它包含8原子接头。
應用
双(3-磺基-N-羟基琥珀酰亚胺酯)辛二酸酯钠盐（BS3）可用于制备蛋白-蛋白、受体-配体和半抗原载体分子缀合物。
儲存類別代碼
11 - Combustible Solids
水污染物質分類（WGK）
WGK 3
閃點（°F）
Not applicable
閃點（°C）
Not applicable
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號，寫有 ‘Lot’或‘Batch’.。
客戶也查看了
Modified apolipoprotein (apo) A-I by artificial sweetener causes severe premature cellular senescence and atherosclerosis with impairment of functional and structural properties of apoA-I in lipid-free and lipid-bound state.
Jang W
Molecular Cell, 31, 461-461 (2011)
Bovine apolipoprotein (apo)A-I displays more enhanced antioxidant and anti-atherosclerotic activity in lipid-free and lipid-bound states than human and porcine apoA-I.
Kim SM
International Journal of Molecular Medicine, 32, 843-843 (2013)
Modelling the structure of latexin-carboxypeptidase A complex based on chemical cross-linking and molecular docking.
Mouradov D
Protein engineering, design & selection : PEDS, 19, 9-16 (2006)
Camilla De Nardis et al.
The Journal of biological chemistry, 292(3), 912-924 (2016-12-14)
LDL receptor-related protein 1 (LRP1) is a highly modular protein and the largest known mammalian endocytic receptor. LRP1 binds and internalizes many plasma components, playing multiple crucial roles as a scavenger and signaling molecule. One major challenge to studying LRP1
Maarten van Dinther et al.
PloS one, 8(4), e62295-e62295 (2013-05-03)
Sclerosteosis is a rare high bone mass disease that is caused by inactivating mutations in the SOST gene. Its gene product, Sclerostin, is a key negative regulator of bone formation and might therefore serve as a target for the anabolic
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務